J Neurol Surg B Skull Base 2014; 75(02): 140-146
DOI: 10.1055/s-0033-1363169
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Sinonasal Inverted Papilloma: Prognostic Factors with Emphasis on Resection Margins

Giant C. Lin
1   Department of Otolaryngology, University of Michigan Health Systems, Ann Arbor, Michigan, United States
,
Sarah Akkina
1   Department of Otolaryngology, University of Michigan Health Systems, Ann Arbor, Michigan, United States
,
Steven Chinn
1   Department of Otolaryngology, University of Michigan Health Systems, Ann Arbor, Michigan, United States
,
Mark E. Prince
1   Department of Otolaryngology, University of Michigan Health Systems, Ann Arbor, Michigan, United States
,
Jonathan B. McHugh
2   Department of Pathology, University of Michigan Health Systems, Ann Arbor, Michigan, United States
,
Thomas Carey
1   Department of Otolaryngology, University of Michigan Health Systems, Ann Arbor, Michigan, United States
,
Mark A. Zacharek
1   Department of Otolaryngology, University of Michigan Health Systems, Ann Arbor, Michigan, United States
› Author Affiliations
Further Information

Publication History

15 June 2013

23 October 2013

Publication Date:
17 February 2014 (online)

Abstract

Objective We review our institution's experience with the treatment of inverted papilloma (IP) with emphasis on the implications of surgical margins for disease control.

Design Retrospective chart review of patients with IP treated at the University of Michigan from 1996 to 2011.

Setting Tertiary care center.

Participants Patients undergoing surgical resection with curative intent for IP.

Main Outcome Measures Overall survival, disease-specific survival, and locoregional control were used as main outcome measures.

Results We studied 129 patients including 19 with carcinoma arising from IP. Disease-free rates at 2, 3, and 5 years were 79.7%, 77.9%, and 61%, respectively. Overall, 10 of 18 recurrences were detected > 2 years from follow-up, with recurrences detected up to 8 years from surgery. For benign disease, obtaining tissue margins outside of the primary specimen for margin control did not affect disease control rates.

Conclusion IP is a disease that requires significant follow-up periods beyond 2 years. For IP without carcinogenesis, acquiring margins outside of the tumor specimen did not appear to affect disease control rates in this study. No clear predictors of malignancy were seen in this study, which highlights the need for further research to predict this phenomenon.

 
  • References

  • 1 Vrabec DP. The inverted Schneiderian papilloma: a 25-year study. Laryngoscope 1994; 104 (5 Pt 1) 582-605
  • 2 Hyams VJ. Papillomas of the nasal cavity and paranasal sinuses. A clinicopathological study of 315 cases. Ann Otol Rhinol Laryngol 1971; 80 (2) 192-206
  • 3 Barnes L. Schneiderian papillomas and nonsalivary glandular neoplasms of the head and neck. Mod Pathol 2002; 15 (3) 279-297
  • 4 Pensak ML. Controversies in Otolaryngology. New York, NY: Thieme; 2001
  • 5 Sham CL, Lee DL, van Hasselt CA, Tong MC. A case-control study of the risk factors associated with sinonasal inverted papilloma. Am J Rhinol Allergy 2010; 24 (1) e37-e40
  • 6 Myers EN, Schramm Jr VL, Barnes Jr EL. Management of inverted papilloma of the nose and paranasal sinuses. Laryngoscope 1981; 91 (12) 2071-2084
  • 7 Lawson W, Ho BT, Shaari CM, Biller HF. Inverted papilloma: a report of 112 cases. Laryngoscope 1995; 105 (3 Pt 1) 282-288
  • 8 Lawson W, Kaufman MR, Biller HF. Treatment outcomes in the management of inverted papilloma: an analysis of 160 cases. Laryngoscope 2003; 113 (9) 1548-1556
  • 9 Lesperance MM, Esclamado RM. Squamous cell carcinoma arising in inverted papilloma. Laryngoscope 1995; 105 (2) 178-183
  • 10 Lombardi D, Tomenzoli D, Buttà L , et al. Limitations and complications of endoscopic surgery for treatment for sinonasal inverted papilloma: a reassessment after 212 cases. Head Neck 2011; 33 (8) 1154-1161
  • 11 Sham CL, Woo JK, van Hasselt CA, Tong MC. Treatment results of sinonasal inverted papilloma: an 18-year study. Am J Rhinol Allergy 2009; 23 (2) 203-211
  • 12 Lawson W, Patel ZM. The evolution of management for inverted papilloma: an analysis of 200 cases. Otolaryngol Head Neck Surg 2009; 140 (3) 330-335
  • 13 Wolfe SG, Schlosser RJ, Bolger WE, Lanza DC, Kennedy DW. Endoscopic and endoscope-assisted resections of inverted sinonasal papillomas. Otolaryngol Head Neck Surg 2004; 131 (3) 174-179
  • 14 Pasquini E, Sciarretta V, Farneti G, Modugno GC, Ceroni AR. Inverted papilloma: report of 89 cases. Am J Otolaryngol 2004; 25 (3) 178-185
  • 15 Krouse JH. Development of a staging system for inverted papilloma. Laryngoscope 2000; 110 (6) 965-968
  • 16 Beck JC, McClatchey KD, Lesperance MM, Esclamado RM, Carey TE, Bradford CR. Human papillomavirus types important in progression of inverted papilloma. Otolaryngol Head Neck Surg 1995; 113 (5) 558-563
  • 17 Beck JC, McClatchey KD, Lesperance MM, Esclamado RM, Carey TE, Bradford CR. Presence of human papillomavirus predicts recurrence of inverted papilloma. Otolaryngol Head Neck Surg 1995; 113 (1) 49-55
  • 18 von Buchwald C, Bradley PJ. Risks of malignancy in inverted papilloma of the nose and paranasal sinuses. Curr Opin Otolaryngol Head Neck Surg 2007; 15 (2) 95-98
  • 19 Weissler MC, Montgomery WW, Turner PA, Montgomery SK, Joseph MP. Inverted papilloma. Ann Otol Rhinol Laryngol 1986; 95 (3 Pt 1) 215-221
  • 20 Woodworth BA, Bhargave GA, Palmer JN , et al. Clinical outcomes of endoscopic and endoscopic-assisted resection of inverted papillomas: a 15-year experience. Am J Rhinol 2007; 21 (5) 591-600
  • 21 Kim DY, Hong SL, Lee CH , et al. Inverted papilloma of the nasal cavity and paranasal sinuses: a Korean multicenter study. Laryngoscope 2012; 122 (3) 487-494
  • 22 Carta F, Verillaud B, Herman P. Role of endoscopic approach in the management of inverted papilloma. Curr Opin Otolaryngol Head Neck Surg 2011; 19 (1) 21-24
  • 23 Cannady SB, Batra PS, Sautter NB, Roh HJ, Citardi MJ. New staging system for sinonasal inverted papilloma in the endoscopic era. Laryngoscope 2007; 117 (7) 1283-1287
  • 24 Sautter NB, Cannady SB, Citardi MJ, Roh HJ, Batra PS. Comparison of open versus endoscopic resection of inverted papilloma. Am J Rhinol 2007; 21 (3) 320-323
  • 25 Mortuaire G, Arzul E, Darras JA, Chevalier D. Surgical management of sinonasal inverted papillomas through endoscopic approach. Eur Arch Otorhinolaryngol 2007; 264 (12) 1419-1424
  • 26 Tufano RP, Thaler ER, Lanza DC, Goldberg AN, Kennedy DW. Endoscopic management of sinonasal inverted papilloma. Am J Rhinol 1999; 13 (6) 423-426
  • 27 Mirza S, Bradley PJ, Acharya A, Stacey M, Jones NS. Sinonasal inverted papillomas: recurrence, and synchronous and metachronous malignancy. J Laryngol Otol 2007; 121 (9) 857-864
  • 28 Lawson W, Le Benger J, Som P, Bernard PJ, Biller HF. Inverted papilloma: an analysis of 87 cases. Laryngoscope 1989; 99 (11) 1117-1124
  • 29 Hasegawa M, Deng Z, Maeda H , et al. Human papillomavirus load and physical status in sinonasal inverted papilloma and squamous cell carcinoma. Rhinology 2012; 50 (1) 87-94
  • 30 Klemi PJ, Joensuu H, Siivonen L, Virolainen E, Syrjänen S, Syrjänen K. Association of DNA aneuploidy with human papillomavirus-induced malignant transformation of sinonasal transitional papillomas. Otolaryngol Head Neck Surg 1989; 100 (6) 563-567